ArticleThe Journal of clinical investigation1997

Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells.

A F Javier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.